Mariner’s Tenaya Therapeutics TNYA Stock Holding History

Mariner’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.2K	Sell	22,000 -71	-0.3%	-$52	﹤0.01%	3506
2025 Q4	$15.7K	Buy	22,071 +1,678	+8%	+$2.28K	﹤0.01%	3495
2025 Q3	$33K	Sell	20,393 -21,025	-51%	-$21.2K	﹤0.01%	3480
2025 Q2	$25.3K	Buy	41,418 +16,374	+65%	+$8.33K	﹤0.01%	3400
2025 Q1	$14.3K	Buy	25,044 +4,021	+19%	+$3.97K	﹤0.01%	3399
2024 Q4	$30.1K	Buy	+21,023	New	+$47.1K	﹤0.01%	3331

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner's TNYA Position: Q1 2026 in Review

Mariner reduced its Tenaya Therapeutics (TNYA) stake by 0.32% in Q1 2026, selling an estimated $52 and leaving 22,000 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3506.

Mariner first reported a position in TNYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $33K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Mariner held 22,000 shares of Tenaya Therapeutics worth $15.2K as of Q1 2026.
Mariner sold 71 Tenaya Therapeutics shares in Q1 2026, an estimated $52.
Tenaya Therapeutics made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3506 holding.
Mariner first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 6 quarters since.
Mariner's Tenaya Therapeutics position peaked at $33K in Q3 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.